Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
03/28/2002 | US20020037332 Licorice extract for use as a medicament |
03/28/2002 | US20020037285 For diseases such as rheumatoid arthritis, atherosclerosis, granulomatous diseases and multiple sclerosis |
03/28/2002 | DE10046272A1 New biphenyl-substituted amino-(iso)quinoline derivatives, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, angina pectoris or restenosis |
03/28/2002 | CA2433157A1 Cyclopentane derivatives as therapeutic agents |
03/28/2002 | CA2423356A1 Zwitterionic tachykinin receptor antagonists |
03/28/2002 | CA2423262A1 Resorcinol derivatives |
03/28/2002 | CA2423156A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
03/28/2002 | CA2423154A1 Imidazole derivatives as raf kinase inhibitors |
03/28/2002 | CA2423071A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
03/28/2002 | CA2423050A1 Pyrazine derivatives as modulators of tyrosine kinases |
03/28/2002 | CA2422991A1 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration |
03/28/2002 | CA2422923A1 Pyridine derivatives with ikb-kinase (ikk-.beta.) inhibiting activity |
03/28/2002 | CA2422911A1 New inhibitors of iapp fibril formation and uses thereof |
03/28/2002 | CA2422820A1 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
03/28/2002 | CA2422686A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment |
03/28/2002 | CA2422215A1 B7-like molecules and uses thereof |
03/28/2002 | CA2421869A1 Tetrahydrofuran derivatives and their use as nk-1 antagonists |
03/28/2002 | CA2421823A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
03/28/2002 | CA2421485A1 Water soluble rapamycin esters |
03/28/2002 | CA2420862A1 Protein phosphatases |
03/27/2002 | EP1191611A2 Piezoelectric element and process for production thereof |
03/27/2002 | EP1191036A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
03/27/2002 | EP1191022A1 Novel dihydropyridine derivative |
03/27/2002 | EP1191021A1 Dihydropyridine derivative |
03/27/2002 | EP1190717A2 Licorice extract for use as a medicament |
03/27/2002 | EP1190716A1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof |
03/27/2002 | EP1190074A1 Recombinant anti-cd40 antibody and uses thereof |
03/27/2002 | EP1190072A2 22012, a novel human carboxypeptidase |
03/27/2002 | EP1190052A1 16405 receptor, a g-protein coupled receptor |
03/27/2002 | EP1190051A2 Human transport proteins |
03/27/2002 | EP1190050A2 Human transcriptional regulator proteins |
03/27/2002 | EP1189946A1 ANTI-$g(a) v?$g(b)3? RECOMBINANT HUMAN ANTIBODIES, NUCLEIC ACIDS ENCODING SAME AND METHODS OF USE |
03/27/2002 | EP1189931A2 Peptide compounds that bind her2 |
03/27/2002 | EP1189930A1 INHIBITORS OF THE INTEGRIN AlPHA V BETA 6 |
03/27/2002 | EP1189929A2 Factor viia inhibitors |
03/27/2002 | EP1189922A1 Steroid derivatives |
03/27/2002 | EP1189917A1 48 human secreted proteins |
03/27/2002 | EP1189916A2 N-pyrazole a 2a receptor agonists |
03/27/2002 | EP1189901A1 Oxazaheterocycles as protease inhibitors |
03/27/2002 | EP1189889A1 Compositions and methods for inhibiting cell death |
03/27/2002 | EP1189888A1 HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS $i(PDE 4) INHIBITORS |
03/27/2002 | EP1189883A2 Substituted pyrrolidines as cell adhesion inhibitors |
03/27/2002 | EP1189882A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor |
03/27/2002 | EP1189881A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
03/27/2002 | EP1189628A1 Combination of tumor necrosis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
03/27/2002 | EP1189627A1 Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
03/27/2002 | EP1189626A1 Method for preventing tumoral growth |
03/27/2002 | EP1189617A1 Novel pharmaceutical combination with analgesic action containing paracetamol and buspirone |
03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
03/27/2002 | EP1189609A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics |
03/27/2002 | EP1189605A2 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
03/27/2002 | EP1189598A1 A method for the improvement of transport across adaptable semi-permeable barriers |
03/27/2002 | EP1189595A1 Ophthalmic compositions in form of aqueous gels |
03/27/2002 | EP1189583A1 Indole derivatives |
03/27/2002 | EP1007534A4 Bh3 interacting domain death agonist |
03/27/2002 | EP0831906B1 Treatment of t cell mediated autoimmune disorders |
03/27/2002 | EP0766670B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
03/27/2002 | EP0730608B1 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
03/27/2002 | EP0639067B1 Use of perfluorcarbons for the preparation of potentiators of the ultrasound induced hyperthermia treatment of biological tissues |
03/27/2002 | CN1342202A Soluble receptor BR43X2 and methods for using them for therapy |
03/27/2002 | CN1342196A Bifidobacterium in treatment of inflammatory disease |
03/27/2002 | CN1342171A Process for production of multiple cross-linked hyaluronic acid derivatives |
03/27/2002 | CN1342167A Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
03/27/2002 | CN1342165A Neurotrophic growth factor |
03/27/2002 | CN1342162A Substituted 2-acyl-3-(heteroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compoistions and methods |
03/27/2002 | CN1342161A Tricyclic inhibitors of poly(ADP-ribose) polymerases |
03/27/2002 | CN1342157A Substituted pyrazoles ASP38 kinase inhibitors |
03/27/2002 | CN1342151A 喹啉和喹喔啉化合物 Quinoline and quinoxaline compounds |
03/27/2002 | CN1342150A Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
03/27/2002 | CN1342149A Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
03/27/2002 | CN1342147A NItroxyderivatives having antiinflammatory, analgesic and antithrombotic activity |
03/27/2002 | CN1342140A 硫代酰胺衍生物 Thioamide derivatives |
03/27/2002 | CN1342079A Treatment and prevention of reactive oxygen metablite-mediated cellular damage |
03/27/2002 | CN1342077A Inhibition of formation of vascular hyperpermeability |
03/27/2002 | CN1342075A Liposome preparations |
03/27/2002 | CN1342073A Antioxidant compositions and methods for companion animals |
03/27/2002 | CN1341593A Proteinase inhibitor |
03/27/2002 | CN1341592A Proteinase inhibitor |
03/27/2002 | CN1341590A Proteinase inhibitor |
03/27/2002 | CN1081635C Substituted pyrrolidine-3-Yl-alkyl-piperidines |
03/27/2002 | CN1081631C N-methyl-N[(1S)-1-phenyl-2-(2S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide |
03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
03/26/2002 | US6362227 Methods for the treatment of tinnitus and other disorders using R(−)ketoptofen |
03/26/2002 | US6362209 Heterocyclic aromatic oxazole compounds and use thereof |
03/26/2002 | US6362204 Controlling immunology; antiinflammatory agents |
03/26/2002 | US6362196 Method to treat pain utilizing benzimidazole NMDA/NR2B antagonists |
03/26/2002 | US6362195 Inhibitor of nitric oxide synthase; central nervous system disorders |
03/26/2002 | US6362193 Antiinflammatory agents |
03/26/2002 | US6362190 Administering compounds such as 3-(2-phenylethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene -carboxamidomethylpyridi nyl)-2-pyrazinone, n'-((1-(aminoiminomethyl)4-piperidinyl) methyl)-n-(3,3-diphenylpropionyl)-l-proline amide |
03/26/2002 | US6362176 Compositions, methods and kits for treating rheumatoid arthritis |
03/26/2002 | US6362007 For diagnosis and therapy of systemic lupus erythematosus and related diseases, and diseases in which epstein-barr virus has been implicated |
03/26/2002 | CA2137551C A novel endothelial cell molecule mediating lymphocyte binding in man |
03/26/2002 | CA2051260C Anti-oxidant system based on a basic amino acid associated with at least one tocopherol or one of its derivatives and at least one non-thiolated polypeptide, and compositions containing such an anti-oxidant system |
03/26/2002 | CA2034096C Controlled absorption naproxen formulation for once-daily administration |
03/21/2002 | WO2002022851A2 Novel tumor-associated marker |
03/21/2002 | WO2002022848A2 Compositions comprising mixtures of human cytokines and methods of producing the same |
03/21/2002 | WO2002022805A2 Modulation of il-2- and il-15-mediated t cell responses |
03/21/2002 | WO2002022801A2 Mammalian receptor genes and uses |
03/21/2002 | WO2002022795A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
03/21/2002 | WO2002022680A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |